Optimizing Patient Access to Orphan Medicinal Products: Lessons from Central and Eastern Europe

This study examines patient access to orphan medicinal products (OMPs) in Central and Eastern Europe (CEE) over the past five years, focusing on seven countries: Bulgaria, Czechia, Hungary, Poland, Romania, Slovakia, and Slovenia. While these jurisdictions have undergone rapid healthcare transformat...

Full description

Bibliographic Details

Published in:	Journal of Market Access & Health Policy
Main Authors:	Tomasz Kluszczynski, Bertalan Nemeth, Magdalena Władysiuk, Marcin Czech, Maria Kamusheva, Nicolae Fotin, Sandra Rose, Tomáš Doležal, Rok Hren
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Subjects:	orphan medicinal products Central and Eastern Europe health technology assessment rare diseases patient access regional collaboration
Online Access:	https://www.mdpi.com/2001-6689/13/2/24